BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 22362843)

  • 1. Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
    Escribano-Subias P; Blanco I; López-Meseguer M; Lopez-Guarch CJ; Roman A; Morales P; Castillo-Palma MJ; Segovia J; Gómez-Sanchez MA; Barberà JA;
    Eur Respir J; 2012 Sep; 40(3):596-603. PubMed ID: 22362843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.
    Hurdman J; Condliffe R; Elliot CA; Davies C; Hill C; Wild JM; Capener D; Sephton P; Hamilton N; Armstrong IJ; Billings C; Lawrie A; Sabroe I; Akil M; O'Toole L; Kiely DG
    Eur Respir J; 2012 Apr; 39(4):945-55. PubMed ID: 21885399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension in France: results from a national registry.
    Humbert M; Sitbon O; Chaouat A; Bertocchi M; Habib G; Gressin V; Yaici A; Weitzenblum E; Cordier JF; Chabot F; Dromer C; Pison C; Reynaud-Gaubert M; Haloun A; Laurent M; Hachulla E; Simonneau G
    Am J Respir Crit Care Med; 2006 May; 173(9):1023-30. PubMed ID: 16456139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.
    Humbert M; Sitbon O; Yaïci A; Montani D; O'Callaghan DS; Jaïs X; Parent F; Savale L; Natali D; Günther S; Chaouat A; Chabot F; Cordier JF; Habib G; Gressin V; Jing ZC; Souza R; Simonneau G;
    Eur Respir J; 2010 Sep; 36(3):549-55. PubMed ID: 20562126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
    Pepke-Zaba J; Delcroix M; Lang I; Mayer E; Jansa P; Ambroz D; Treacy C; D'Armini AM; Morsolini M; Snijder R; Bresser P; Torbicki A; Kristensen B; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Hamid AM; Jaïs X; Simonneau G
    Circulation; 2011 Nov; 124(18):1973-81. PubMed ID: 21969018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
    Roman A; Barbera JA; Castillo MJ; Muñoz R; Escribano P
    Arch Bronconeumol; 2013 May; 49(5):181-8. PubMed ID: 23452896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
    Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
    Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
    Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.
    del Cerro Marín MJ; Sabaté Rotés A; Rodriguez Ogando A; Mendoza Soto A; Quero Jiménez M; Gavilán Camacho JL; Raposo Sonnenfeld I; Moya Bonora A; Albert Brotons DC; Moreno Galdó A;
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1421-9. PubMed ID: 25379685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival.
    Cogswell R; Kobashigawa E; McGlothlin D; Shaw R; De Marco T
    J Heart Lung Transplant; 2012 Nov; 31(11):1165-70. PubMed ID: 23062726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe.
    Skride A; Sablinskis K; Lejnieks A; Rudzitis A; Lang I
    Pulm Circ; 2018; 8(3):2045894018780521. PubMed ID: 29767576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
    Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
    Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
    Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
    Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcomes in chronic thromboembolic pulmonary hypertension: From expert centers to a nationwide perspective.
    Escribano-Subías P; Del Pozo R; Román-Broto A; Domingo Morera JA; Lara-Padrón A; Elías Hernández T; Molina-Ferragut L; Blanco I; Cortina J; Barberà JA;
    Int J Cardiol; 2016 Jan; 203():938-44. PubMed ID: 26618257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term data from the Swiss pulmonary hypertension registry.
    Mueller-Mottet S; Stricker H; Domenighetti G; Azzola A; Geiser T; Schwerzmann M; Weilenmann D; Schoch O; Fellrath JM; Rochat T; Lador F; Beghetti M; Nicod L; Aubert JD; Popov V; Speich R; Keusch S; Hasler E; Huber LC; Grendelmeier P; Tamm M; Ulrich S
    Respiration; 2015; 89(2):127-40. PubMed ID: 25661477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.